Literature DB >> 15161661

Inhibition of intimal hyperplasia in transgenic mice conditionally expressing the chemokine-binding protein M3.

Robert Pyo1, Kristian K Jensen, Maria T Wiekowski, Denise Manfra, Antonio Alcami, Mark B Taubman, Sergio A Lira.   

Abstract

Chemokines have been implicated in the pathogenesis of a wide variety of diseases. This report describes the generation of transgenic mice that conditionally express M3, a herpesvirus protein that binds and inhibits chemokines. In response to doxycycline, M3 expression was induced in a variety of tissues and M3 was detectable in the blood by Western blotting. No gross or histological abnormalities were seen in mice expressing M3. To determine whether M3 expression could modify a significant pathophysiological response, we examined its effect on the development of intimal hyperplasia in response to femoral arterial injury. Intimal hyperplasia is thought to play a critical role in the development of restenosis after percutaneous transluminal coronary angioplasty and in the progression of atherosclerosis. Induction of M3 expression resulted in a 67% reduction in intimal area and a 68% reduction in intimal/medial ratio after femoral artery injury. These data support a role for chemokines in regulating intimal hyperplasia and suggest that M3 may be effective in attenuating this process. This transgenic mouse model should be a valuable tool for investigating the role of chemokines in a variety of pathological states.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15161661      PMCID: PMC1615775          DOI: 10.1016/S0002-9440(10)63785-6

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  64 in total

Review 1.  The biology of chemokines and their receptors.

Authors:  D Rossi; A Zlotnik
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

Review 2.  Molecular mechanisms in intimal hyperplasia.

Authors:  A C Newby; A B Zaltsman
Journal:  J Pathol       Date:  2000-02       Impact factor: 7.996

3.  EGF-genistein inhibits neointimal hyperplasia after vascular injury in an experimental restenosis model.

Authors:  V N Trieu; R K Narla; D E Myers; F M Uckun
Journal:  J Cardiovasc Pharmacol       Date:  2000-04       Impact factor: 3.105

4.  Human vascular smooth muscle cells possess functional CCR5.

Authors:  A D Schecter; T M Calderon; A B Berman; C M McManus; J T Fallon; M Rossikhina; W Zhao; G Christ; J W Berman; M B Taubman
Journal:  J Biol Chem       Date:  2000-02-25       Impact factor: 5.157

5.  Mouse model of femoral artery denudation injury associated with the rapid accumulation of adhesion molecules on the luminal surface and recruitment of neutrophils.

Authors:  M Roque; J T Fallon; J J Badimon; W X Zhang; M B Taubman; E D Reis
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-02       Impact factor: 8.311

6.  The viral anti-inflammatory chemokine-binding protein M-T7 reduces intimal hyperplasia after vascular injury.

Authors:  L Liu; A Lalani; E Dai; B Seet; C Macauley; R Singh; L Fan; G McFadden; A Lucas
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

7.  Identification of a gammaherpesvirus selective chemokine binding protein that inhibits chemokine action.

Authors:  V van Berkel; J Barrett; H L Tiffany; D H Fremont; P M Murphy; G McFadden; S H Speck; I V Virgin HW
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

8.  Hyperplasia of coronary intima in young males in relation to development of coronary heart disease in adults.

Authors:  V S Zhdanov; N H Sternby; I P Drobkova; I E Galakhov
Journal:  Int J Cardiol       Date:  2000-10       Impact factor: 4.164

9.  Interleukin-10 inhibits intimal hyperplasia after angioplasty or stent implantation in hypercholesterolemic rabbits.

Authors:  L J Feldman; L Aguirre; M Ziol; J P Bridou; N Nevo; J B Michel; P G Steg
Journal:  Circulation       Date:  2000-02-29       Impact factor: 29.690

10.  Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma.

Authors:  T Y Yang; S C Chen; M W Leach; D Manfra; B Homey; M Wiekowski; L Sullivan; C H Jenh; S K Narula; S W Chensue; S A Lira
Journal:  J Exp Med       Date:  2000-02-07       Impact factor: 14.307

View more
  9 in total

1.  Rodent herpesvirus Peru encodes a secreted chemokine decoy receptor.

Authors:  Olga Y Lubman; Marina Cella; Xinxin Wang; Kristen Monte; Deborah J Lenschow; Yina H Huang; Daved H Fremont
Journal:  J Virol       Date:  2013-10-30       Impact factor: 5.103

Review 2.  Reversible or irreversible remodeling in pulmonary arterial hypertension.

Authors:  Seiichiro Sakao; Koichiro Tatsumi; Norbert F Voelkel
Journal:  Am J Respir Cell Mol Biol       Date:  2009-12-11       Impact factor: 6.914

Review 3.  The biology of chemokines and their receptors.

Authors:  Sergio A Lira; Glaucia C Furtado
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

Review 4.  Mechanisms of immunomodulation by mammalian and viral decoy receptors: insights from structures.

Authors:  Jan Felix; Savvas N Savvides
Journal:  Nat Rev Immunol       Date:  2016-12-28       Impact factor: 53.106

Review 5.  Subversion of cytokine networks by virally encoded decoy receptors.

Authors:  Megan L Epperson; Chung A Lee; Daved H Fremont
Journal:  Immunol Rev       Date:  2012-11       Impact factor: 12.988

6.  Dual GPCR and GAG mimicry by the M3 chemokine decoy receptor.

Authors:  Jennifer M Alexander-Brett; Daved H Fremont
Journal:  J Exp Med       Date:  2007-12-10       Impact factor: 14.307

7.  Chemokine binding protein 'M3' limits atherosclerosis in apolipoprotein E-/- mice.

Authors:  Dhanya Ravindran; Anisyah Ridiandries; Laura Z Vanags; Rodney Henriquez; Siân Cartland; Joanne T M Tan; Christina A Bursill
Journal:  PLoS One       Date:  2017-03-10       Impact factor: 3.240

8.  IL-10 based immunomodulation initiated at birth extends lifespan in a familial mouse model of amyotrophic lateral sclerosis.

Authors:  Michael R Strickland; Kristen R Ibanez; Mariya Yaroshenko; Carolina Ceballos Diaz; David R Borchelt; Paramita Chakrabarty
Journal:  Sci Rep       Date:  2020-11-30       Impact factor: 4.379

Review 9.  Deriving Immune Modulating Drugs from Viruses-A New Class of Biologics.

Authors:  Jordan R Yaron; Liqiang Zhang; Qiuyun Guo; Michelle Burgin; Lauren N Schutz; Enkidia Awo; Lyn Wise; Kurt L Krause; Cristhian J Ildefonso; Jacek M Kwiecien; Michael Juby; Masmudur M Rahman; Hao Chen; Richard W Moyer; Antonio Alcami; Grant McFadden; Alexandra R Lucas
Journal:  J Clin Med       Date:  2020-03-31       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.